Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest Organofluorides Stories

2013-11-05 23:22:03

In a release from the U.S. Department of Justice (DOJ), Johnson & Johnson will pay out more than $2.2 Billion after allegations of promotion of Risperdal, Invega and Natrecor for uses not approved as safe and effective and physician kickbacks pertaining to the prescription drugs. Columbus, OH (PRWEB) November 05, 2013 Risperdal lawsuits may take a new turn with news coming out of the U.S. Department of Justice (DOJ), according to the experienced personal injury law firm of Wright...

2013-11-05 23:01:26

Global healthcare giant Johnson & Johnson and its Janssen subsidiary will pay more than $2.2 billion to settle allegations related to the off-label marketing of the anti-psychotic drug Risperdal, plus two other drugs. Parker Waichman LLP commends several whistleblowers who will be awarded millions of dollars in compensation for their efforts to expose alleged fraud. New York, New York (PRWEB) November 05, 2013 Parker Waichman LLP, a national law firm dedicated to protecting the rights...

2013-11-05 16:27:39

FORT LAUDERDALE, Fla., Nov. 5, 2013 /PRNewswire/ -- South Florida consumer advocate and leading false claims attorney Gary M. Farmer, Jr., a partner with Farmer, Jaffe, Weissing, Edwards, Fistos & Lehrman, P.L., has successfully litigated his third major false claims case against a global pharmaceutical company. Today, the United States Department of Justice announced a settlement against pharmaceutical giant Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals Inc. Johnson...

2013-11-05 08:36:13

The availability of Brisdelle(TM) (Paroxetine) capsules offers the millions of women in the U.S. affected by moderate to severe hot flashes associated with menopause a first-of-its-kind treatment option MIAMI and NEW YORK, Nov. 5, 2013 /PRNewswire/ -- Noven Pharmaceuticals, Inc. today announced that Brisdelle(TM) (paroxetine) capsules, 7.5 mg, is now available by prescription nationwide. Brisdelle is the first and only FDA-approved, non-hormonal treatment for moderate to severe vasomotor...

2013-11-04 23:19:01

Reportbuyer.com just published a new market research report: PharmaPoint: Non-Small Cell Lung Cancer - India Drug Forecast and Market Analysis to 2022. London (PRWEB) November 04, 2013 PharmaPoint: Non-Small Cell Lung Cancer - India Drug Forecast and Market Analysis to 2022 Summary Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in men and women. Historically, the treatment paradigm has centered around chemotherapy. However, the launch...

2013-11-04 23:04:31

Reportbuyer.com just published a new market research report: PharmaPoint: Non-Small Cell Lung Cancer - UK Drug Forecast and Market Analysis to 2022. London (PRWEB) November 04, 2013 PharmaPoint: Non-Small Cell Lung Cancer - UK Drug Forecast and Market Analysis to 2022 Summary Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in men and women. Historically, the treatment paradigm has centered around chemotherapy. However, the launch of...

2013-11-04 23:01:50

The Firm is investigating an alleged association between Risperdal and gynecomastia, or male breast growth. New York, NY (PRWEB) November 04, 2013 As Risperdal lawsuits (http://www.therisperdallawsuit.com) involving allegations that use of the antipsychotic drug caused gynecomastia, or male breast growth, continue to mount in courts throughout the country, Bernstein Liebhard LLP notes that Johnson & Johnson has agreed to pay $2.2 billion to settle a government probe into the marketing...

2013-11-04 23:00:33

http://www.DrugNews.net is the web’s premier source for prescription drug warnings, research, side effects and legal news. Visit the DrugNews Center today. New York, NY (PRWEB) November 04, 2013 The medication safety advocates at DrugNews.net are announcing the launch of a new resource site for patients taking the antipsychotic drug Risperdal. Information will be available on studies into the drug’s side effects, the issuance of safety alerts, as well as legal news for any injury...

2013-11-04 12:28:23

NEW BRUNSWICK, N.J., Nov. 4, 2013 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) and its subsidiaries, Janssen Pharmaceuticals, Inc. and Scios Inc., today announced they have finalized previously disclosed settlement agreements with the U.S. Department of Justice (DOJ) and 45 states resolving federal investigations and state Medicaid claims related to past promotional practices of RISPERDAL(®) from 1999 through 2005, and other matters. The resolution includes total settlement...

2013-11-03 23:01:55

The Firm is investigating potential Lipitor lawsuits that allege an association between the use of Lipitor and diabetes. New York, New York (PRWEB) November 03, 2013 Court records from a around the country indicate that more plaintiffs have filed Lipitor lawsuits (http://www.thelipitorlawsuit.com/) which allege the use of the popular statin drug caused patients to develop new-onset Type 2 diabetes, Bernstein Liebhard LLP reports. According to a report published by Bluefield Daily...